Background-Among patients with implantable defibrillators (ICD), use of remote patient monitoring (RPM) is associated with lower risk of death and rehospitalization. Standard ICD RPM can be supplemented with weight and blood pressure data. It is not known whether standard RPM plus routine weight and blood pressure transmission (RPM+) is associated with better outcomes. Methods and Results-RPM+ patients (n=4106) were compared with patients who only transmitted standard ICD RPM data (n=14 183). Logistic regression models identified patient, physician, and hospital characteristics associated with RPM+ utilization. Mortality and rehospitalization were examined using landmark analyses at 180 days after ICD implant in Medicare fee-for-service patients. In these analyses, we examined the independent association between RPM+ utilization and times to events up to 3 years after device implantation with Cox regression models. We further examined whether the association between RPM+ and outcomes varied by frequency or type of transmissions. Determinants of RPM+ utilization included impaired ejection fraction, cardiac resynchronization therapy, and institutional practice. The risk of mortality of RPM+ patients was similar to standard ICD RPM patients (hazard ratio, 1.06; 95% confidence interval, 0.94-1.19; P=0.34). RPM+ patients also had similar risks of all-cause hospitalization (subdistribution hazard ratio, 1.03; 95% confidence interval, 0.94-1.14; P=0.52), cardiovascular hospitalization (subdistribution hazard ratio, 0.92; 95% confidence interval, 0.83-1.02; P=0.15), or heart failure hospitalizations (subdistribution hazard ratio, 0.90; 95% confidence interval, 0.78-1.05; P=0.18). RPM+ transmission frequency was not associated with outcomes. Conclusions-In patients using standard ICD RPM, the added transmission of weight and blood pressure data was not associated with improved outcomes. (Circ Cardiovasc Qual Outcomes. 2017;10:e003087.
I mplantable cardioverter defibrillators (ICD) improve survival in selected patient populations. [1] [2] [3] Most modern ICDs are capable of providing automatic wireless remote transmissions of device function and clinical status, thereby allowing clinicians to consider modifications in therapy without a face-to-face interaction with the patient. [4] [5] [6] Standard ICD remote patient monitoring (RPM) is safe, efficient, and has been associated with decreased risk of mortality and rehospitalization. 7, 8 Clinical guidelines and statements from professional societies strongly advocate routine use of standard ICD RPM [9] [10] [11] ; however, there is significant underutilization of this technology. 12 Current technological advances have enabled remote transmission of weight and blood pressure information in addition to standard ICD RPM (RPM+). Given that measurement of blood pressure and weight is recommended in current guidelines, 13, 14 telemonitoring of these measures has emerged as a central component of heart failure management despite little evidence that RPM+ affects patient outcome. [15] [16] [17] 
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Heart failure disease management programs have been developed to improve quality of life and reduce rehospitalization and mortality. 18 The initial weight and blood pressure telemonitoring studies have demonstrated a decrease in mortality and rehospitalization rates 19, 20 ; however, newer larger randomized multicenter trials have shown no benefit. [15] [16] [17] 19, 21 Despite the absence of high-quality evidence of their effectiveness, investment in telemonitoring of weight and blood pressure is expanding, in part, because of the increasing availability of devices capable of automated measurement and Weight/Blood Pressure Remote Monitor and Outcomes wireless data transmission. 20, [22] [23] [24] [25] [26] It is assumed that this automated functionality would result in clinical benefit; however, it is not known whether the addition of RPM+ transmissions confers any incremental benefit compared with the standard ICD RPM alone. This observational cohort study is designed to determine whether RPM+ is associated with better outcomes compared with the benefits derived from using the standard ICD RPM alone.
Methods

Datasets and Study Population
The data sources and populations used in this study have been described in detail. 7, 12 Briefly, the population was derived by linking 3 data sets: (1) the American College of Cardiology Foundation National Cardiovascular Data Registry ICD registry; (2) the Boston Scientific Corporation ALTITUDE database; and (3) Medicare administrative claims data. Only patients who were implanted with LATITUDE RPM-enabled devices between January 2006 and March 2010 in the ALTITUDE database and transmitted at least 1 time within 180 days of device implantation were included. The patients were divided into 2 groups: (1) the standard ICD RPM group if they used standard ICD RPM but did not transmit blood pressure or weight information within 180 days of device implantation and (2) the RPM+ group if they transmitted blood pressure and weight measurements in addition to the standard ICD RPM information within 180 days of device implantation. The Yale University Human Investigation Committee approved the present analysis with waiver of informed consent.
Data Analysis
We compared the patient, physician, hospital, and regional characteristics of the RPM+ and standard ICD RPM groups. Continuous
WHAT IS KNOWN
• Telemonitoring approaches to heart failure management have not been definitively demonstrated to improve outcomes.
• With the increasing availability of automated devices capable of remotely transmitting weight and blood pressure information, there is growing interest in incorporating these data in clinical heart failure management.
• Use of standard device remote monitoring is associated with lower risk of death and rehospitalization among patients with implantable defibrillators, but it is unclear whether supplementation with automated weight and blood pressure transmissions improves outcomes.
WHAT THE STUDY ADDS
• In this real-world study of patients undergoing the first-time defibrillator implantation, the addition of blood pressure and weight remote monitoring to standard device remote monitoring was not associated with clinical benefit. • These findings should be taken into consideration when developing multidisciplinary heart failure management programs that incorporate automated telemonitoring of weight and blood pressure. included in the model was extremely low, generally <1% except for some hospital characteristics (hospital ownership, teaching status, facility type, beds, and region) for which the missing rate was 3.6%, median household income and education with a missing rate of 4%, and operator training with missing rate of 17%. Multiple imputation techniques were used for missing variables, and the coefficients of 5 rounds of imputation were combined to obtain the final estimates for the models. Model discrimination in the derivation and validation cohorts was evaluated by C statistic. For model validation, the coefficients of the model from the derivation cohort were applied to the validation cohort assessing the predicted versus observed RPM+ utilization rate within deciles of the predicted RPM+ utilization rate. Models were repeated using hierarchical techniques to account for clustering of data (ie, patients within hospitals). 27 This approach allows the calculation of a hospital-specific median odds ratio that represented the influence of the hospital variation on patient RPM+ use. The median odds ratio is defined as the median value of the odds ratios between hospitals at highest risk and at lowest risk when chosen at random, and as such reflects hospital-level variation independent of prevalence and patient clustering.
In the subset of Medicare fee-for-service beneficiaries, the main outcomes of all-cause mortality, all-cause rehospitalization, cardiovascular rehospitalization, and heart failure rehospitalization were evaluated. All-cause mortality was determined from death dates in the Medicare denominator files, and rehospitalization outcomes were determined by inpatient claims. Patients were followed up for a minimum of 2 years after implant. Patients were categorized into standard ICD RPM and RPM+ groups after a landmark time of 180 days after implant. 28 For all-cause mortality, Cox proportional hazard models were used to examine the independent association between standard ICD RPM and RPM+ utilization and outcomes up to 3 years after device implant. Kaplan-Meier analyses were used to estimate mortality. For all-cause rehospitalization, cardiovascular rehospitalization and heart failure rehospitalization, Fine-Gray models were used to account for the competing risk of death. We reported hazard ratios (HR) and subdistribution HRs and their corresponding 95% confidence intervals (CI) based on robust sandwich variance estimates to account for clustering of patients within hospitals. Prespecified subgroup analyses were performed on the following subgroups: age, sex, race/ethnicity, median household income, ICD type (ICD versus cardiac resynchronization therapy), indication (primary versus secondary prevention), and cardiomyopathy type (ischemic versus nonischemic).
A dose-response analysis was performed to assess whether the degree of compliance with weight and blood pressure transmissions was associated with outcomes. The number of weight and blood pressure transmissions per week from first transmission until the 180-day landmark was quantified, and the RPM+ patients were stratified into tertiles with low, medium, and high RPM+ transmission. The relationship to rehospitalization and mortality was determined across tertiles and compared with patients with standard ICD RPM alone.
Although RPM+ is mainly clinically utilized as a combination of weight and blood pressure transmissions, it is possible that only 1 measure-but not both-may contribute to outcomes. Thus, to dissociate the effect of blood pressure remote monitoring from weight BP indicates blood pressure; BS indicates Boston Scientific; BUN, blood urea nitrogen; CABG, coronary artery bypass grafting; CATH, cardiac catheterization; CHF, congestive heart failure; COTH, council of teaching hospitals; EP, electrophysiology; HD, heart disease; HMO, Health Maintenance Organization; ICD, implantable cardioverter defibrillator; LBBB, left bundle branch block; MI, myocardial infarction; NYHA, New York Heart Association; Occ hous unit w/telephone, occupied house unit with telephone; PCI, percutaneous coronary intervention; Persons 25+ w/4+ y college, persons >25 years old with 4 years or more college degree; RBBB, right bundle branch block; and RPM, remote patient monitoring. 
Results
Patient Characteristics
A total of 18 289 patients were studied. The patients were divided into the standard ICD RPM group (n=14 183) and the RPM+ group (n=4106). Table 1 shows the baseline characteristics of patients using RPM+ compared with patients with standard ICD RPM. The primary determinants of RPM+ utilization are shown in Figure 1 
Outcomes
Of the 18 289 patients in the full cohort, outcomes were evaluated in the subset of Medicare fee-for-service beneficiaries (n=7551). This included 5784 patients with standard ICD RPM and 1767 patients with RPM+ (see Table I Figures 2 and 3 , respectively. Kaplan-Meier survival curves comparing the 3-year survival between RPM+ and standard ICD RPM patients are shown in Figure 4 . There was no mortality difference between patients using RPM+ and standard ICD RPM in any of the prespecified subgroups ( Table 2 ).
The 3-year all-cause rehospitalization rate was 51.5% with median follow-up of 713 days. Multivariable analysis revealed that compared with the standard ICD RPM, use of RPM+ was not associated with differences in risks of all-cause rehospitalization (subdistribution HR, 1.032; 95% CI, 0.938-1.136; P=0.52), cardiac rehospitalization (subdistribution HR, 0.924; 95% CI, 0.830-1.029; P=0.15), or heart failure rehospitalization (subdistribution HR, 0.904; 95% CI, 0.781-1.046; P=0.18). There were no differences in heart failure rehospitalization between patients with RPM+ and standard ICD RPM in any of the prespecified subgroups except race (Table 2 ). 
Weight and Blood Pressure Remote Monitoring Compliance
Based on tertiles of blood pressure and weight transmissions per week, patients were classified into low-intensity (median, 1.1; range, 0.1-2.2), intermediate-intensity (median, 4.6; range, 2.2-8.2), and high-intensity (median, 12.3; range, 8.2-13.9) users of RPM+. There was no difference in the risk of mortality, all-cause rehospitalization, cardiovascular rehospitalization, or heart failure hospitalization in the RPM+ group compared with the standard ICD RPM group regardless of the intensity of RPM+ use (Table 3) . all-cause rehospitalization, cardiovascular rehospitalization, or heart failure hospitalization among those who transmitted either weight or blood pressure data compared with the standard ICD RPM group regardless of compliance (Table 3) .
Discussion
In an observational study of patients undergoing first-time ICD implantation, patients who transmitted weight and blood pressure measurements in addition to the standard ICD RPM were at similar risk of mortality and rehospitalization compared with patients who transmitted standard RPM alone. These findings were consistent across key subgroups, frequency of RPM+ data transmission, and the type of information included in the transmissions. They suggest that a strategy of supplementing standard ICD RPM with weight and blood pressure data may not improve patient outcomes.
Multidisciplinary heart failure management programs improve survival and decrease heart failure hospitalization and have been endorsed by professional societies. 30 However, these programs are resource intensive and can be inconvenient to patients. Accordingly, there has been great interest in replacing direct patient contact with telemonitoring using remotely transmitted measures. However, although most heart failure management programs incorporate weight and blood pressure measurements, the efficacy of remotely transmitting these data remains uncertain. 16, 31 Early studies demonstrated the clinical efficacy of weight and blood pressure telemonitoring, but this finding was not confirmed in larger randomized trials. [15] [16] [17] 19, 21, 31 Despite the lack of concrete evidence supporting clinical efficacy, enthusiasm for heart failure telemonitoring continues to grow with the commercial introduction of automated devices that remotely transmit weight, blood pressure, and other physiological information. There is continued interest in leveraging this technology for heart failure management in clinical programs and commercial initiatives despite the paucity of data on efficacy. 20, [22] [23] [24] [25] [26] Importantly, there has been no attempt to distinguish between the effects of standard ICD RPM from RPM+. Although ICD RPM is associated with lower risks of death and rehospitalization, 7, 8 it is unclear whether RPM+ carries any additional benefit. The present study is the first to demonstrate that the addition of weight and blood pressure transmissions is not associated with incremental benefit over the standard ICD RPM in a real-world setting. Moreover, differences in compliance do not seem to explain the absence of benefit associated with RPM+ use. Patients with RPM+ did not seem to benefit from this technology regardless of the frequency with which they transmitted data. This is important because low compliance has been purported as a major reason for lack of telemonitoring efficacy, 32 and thus the automated feature of Furthermore, neither the common practice consisting of combined blood pressure and weight transmissions nor a practice utilizing either one of these measurements was associated with improved outcomes. The data strongly suggest that as used in real-world practice, weight and blood pressure transmissions are not associated with clinical benefit. Although it is possible that RPM+ may improve other measures that were not studied, the findings of our study are consistent with a recent large randomized trial. 16 Whether implanted hemodynamic measurements might be more successful and lead to earlier and more effective interventions remains to be seen.
Limitations
Our study is observational and has certain limitations. Although we used appropriate methodology to account for differences in measured baseline characteristics, we cannot exclude the possibility of unknown and unmeasured confounders. It cannot be determined whether the transmitted data are given to the electrophysiologist only or to the cardiologist treating the patient or whether the practice/hospital has a heart failure specialist. Furthermore, there was no standardized intervention utilized in response to the transmitted RPM+ data so it is not known how practices incorporated this information into their workflow. One cannot exclude specific patterns of RPM+ use that may be associated with improved outcomes; however, this is representative of real-world clinical practice where there is substantial variation in the assessment and management of patients with heart failure. 31 
Conclusions
In this real-world study of patients undergoing the first-time ICD implantation, the addition of blood pressure and weight remote monitoring to the standard ICD RPM was not associated with any clinical benefit. The value of the exponential growth of heart failure management programs relying on automated devices providing this type of remote monitoring should be reassessed in light of these findings. 
